The Possible Role of PET Imaging Toward Individualized Management of Bone and Soft Tissue Malignancies-Reference-Cited by-同舟云学术

The Possible Role of PET Imaging Toward Individualized Management of Bone and Soft Tissue Malignancies

Published:2016-07 Issue:3 Volume:11 Page:285-296
ISSN:1556-8598
Container-title:PET Clinics
language:en
Short-container-title:PET Clinics

Author:

Tabacchi Elena,Fanti Stefano,Nanni Cristina

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,General Medicine,Radiation

Reference78 articles.

1. Improved prognostication in soft tissue sarcoma: independent information from vascular invasion, necrosis, growth pattern, and immunostaining using whole tumor sections and tissue microarrays;Engellau;Hum Pathol,2005

2. International Agency for Research on Cancer. WHO Classification of soft tissue tumours. Available at: http://www.iarc.fr/en/publications/pdfs-online/pat-gen/bb5/bb5-classifsofttissue.pdf. Accessed August 26, 2012.

3. Prereferral MRI use in patients with musculoskeletal tumors is not excessive;Martin;Clin Orthop Relat Res,2012

4. Simple guidelines for efficient referral of soft-tissue sarcomas: a population-based evaluation of adherence to guidelines and referral patterns;Styring;J Bone Joint Surg Am,2012

5. Principles of staging of soft-tissue sarcomas;Peabody;Clin Orthop Relat Res,1993

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Contribution of pet/mr in muskuloskeletal malignancies;The Quarterly Journal of Nuclear Medicine and Molecular Imaging;2021-12

2. Fluorine-18-fluorodeoxyglucose (FDG) positron emission tomography (PET) computed tomography (CT) for the detection of bone, lung, and lymph node metastases in rhabdomyosarcoma;Cochrane Database of Systematic Reviews;2021-11-09

3. PET/MR for evaluation of musculoskeletal malignancies;Clinical and Translational Imaging;2021-11-05

4. PET Imaging of Peripheral Nerve Tumors;PET Clinics;2019-01

5. Current State of Image Guidance in Radiation Oncology: Implications for PTV Margin Expansion and Adaptive Therapy;Seminars in Radiation Oncology;2018-07